We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioquell | LSE:BQE | London | Ordinary Share | GB0004992003 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 597.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMBQE
RNS Number : 6221S
Bioquell PLC
10 July 2015
10 July, 2015
Bioquell PLC
Trading Update
Bioquell PLC ("Bioquell") (LSE symbol: BQE) - provider of specialist microbiological control technologies to the international Healthcare, Life Sciences & Defence markets today announces an update on its trading performance for the six months ended 30 June 2015.
Trading was in line with the Board's expectations.
We estimate that revenues for the Group's continuing activities (the Bio division) for the six months ended 30 June 2015, will be approximately GBP12.5 million (H1 2014: GBP12.3 million), an increase in the period of some 2%.
The Company had net cash of GBP47.7 million at 30 June 2015, of which GBP1.4m was used to pay the 2014 final dividend on 2 July.
The strategic review announced on 18 May 2015 is ongoing and there is no further update at this stage.
The interim results for the six months ended 30 June, 2015 are expected to be announced on 26 August, 2015.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTEAEXNEDKSEFF
1 Year Bioquell Chart |
1 Month Bioquell Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions